Chinese medicine yin-yang; Peptide arrays fight terrorists;

> Tianyin Pharmaceutical, a maker of modernized traditional Chinese medicines, has received GMP certification for a new production facility from China's State Food and Drug Administration. Release

> Arrayit Corp. will provide its proprietary peptide microarray manufacturing platform to the U.S. Centers for Disease Control and Prevention for use in deciphering and combating infectious agents from terrorist attacks. Announcement

> Some 400 manufacturing jobs have been cut at a Teva plant in Prague, to be replaced next year by 300 jobs following a main plant expansion. Release

> Dionex, a maker of liquid chromatography analysis systems, is picking up HPLC assets from ESA Biosciences. Announcement

> Vetter of Ravensburg, Germany, is opening a 25,000-square-foot customer service facility in Chicago for the aseptic filling of very small quantities of injection products.  Release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.